- Home
- NTZ vs MAIA Comparison
NTZ vs MAIA Comparison
Compare NTZ & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- MAIA
- Stock Information
- Founded
- NTZ 1959
- MAIA 2018
- Country
- NTZ Italy
- MAIA United States
- Employees
- NTZ N/A
- MAIA N/A
- Industry
- NTZ Home Furnishings
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- MAIA Health Care
- Exchange
- NTZ Nasdaq
- MAIA Nasdaq
- Market Cap
- NTZ 52.2M
- MAIA 44.8M
- IPO Year
- NTZ 1993
- MAIA 2022
- Fundamental
- Price
- NTZ $4.97
- MAIA $1.63
- Analyst Decision
- NTZ
- MAIA
- Analyst Count
- NTZ 0
- MAIA 0
- Target Price
- NTZ N/A
- MAIA N/A
- AVG Volume (30 Days)
- NTZ 5.0K
- MAIA 120.2K
- Earning Date
- NTZ 04-08-2025
- MAIA 05-13-2025
- Dividend Yield
- NTZ N/A
- MAIA N/A
- EPS Growth
- NTZ N/A
- MAIA N/A
- EPS
- NTZ N/A
- MAIA N/A
- Revenue
- NTZ $365,846,531.00
- MAIA N/A
- Revenue This Year
- NTZ N/A
- MAIA N/A
- Revenue Next Year
- NTZ N/A
- MAIA N/A
- P/E Ratio
- NTZ N/A
- MAIA N/A
- Revenue Growth
- NTZ N/A
- MAIA N/A
- 52 Week Low
- NTZ $3.80
- MAIA $1.45
- 52 Week High
- NTZ $6.43
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- NTZ 60.37
- MAIA 46.76
- Support Level
- NTZ $4.39
- MAIA $1.45
- Resistance Level
- NTZ $5.20
- MAIA $1.95
- Average True Range (ATR)
- NTZ 0.26
- MAIA 0.11
- MACD
- NTZ 0.04
- MAIA -0.00
- Stochastic Oscillator
- NTZ 57.94
- MAIA 36.00
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.